Table 2.
Mode | Mass | Time | Putative identification | Action on preimplantation development (species) |
---|---|---|---|---|
(−) | 152.0 | 0.80 | 3‐Sulfino‐l‐alanine | Increase development to blastocyst stage (rats) a |
(−) | 215.0 | 0.71 | Glucose/fructose | Phosphorylates mTORC1 and ribosomal S6 kinase a (rabbit) b ; increased reactive oxygen species (mouse) c |
(−) | 217.0 | 0.71 | Glucose/fructose | Phosphorylates mTORC1 and ribosomal S6 kinase a (rabbit) b ; increased reactive oxygen species (mouse) c |
(−) | 133.0 | 1.04 | Malate | Improve development to 8‐cell stage (hamster) d |
(−) | 133.0 | 1.19 | Malate | Improve development to 8‐cell stage (hamster) d |
(−) | 116.0 | 1.16 | N‐Acetylglycine | Increase development to blastocyst stage (rats) a |
(−) | 116.0 | 1.16 | N‐Acetylglycine | Increase development to blastocyst stage (rats) a |
(−) | 160.1 | 0.89 | N‐Methyl‐l‐glutamate | Increase development to blastocyst stage (rats) a |
(−) | 124.0 | 0.71 | Taurine | Increased embryo viability (bovine) e ; increase development to blastocyst stage (rats) a |
(+) | 157.0 | 0.98 | (R)‐Malate | Improve development to 8‐cell stage (hamster) d |
(+) | 132.1 | 0.77 | 5‐Aminolevulinic acid | Impaired development to the blastocyst stage (mouse) f |
(+) | 137.0 | 6.07 | Allopurinol | Inhibits morula and blastocyst formation (rabbit) g |
(+) | 391.3 | 16.57 | Bis(2‐ethylhexyl) phthalate | Impaired development to the blastocyst stage (mouse) h |
(+) | 279.2 | 14.66 | Dibutyl phthalate | Impaired development to the blastocyst stage (mouse) h |
(+) | 162.1 | 0.94 | l‐Carnitine | Decrease size of lipid bodies (mice) i ; increased rate of ATP:ADP conversion (bovine) j |
(+) | 132.1 | 2.51 | Leucine | Altered gene expression in mTORC dependent manner (rabbit) b |
(+) | 132.1 | 2.24 | Leucine | Regulated TE motility (mouse) k |
(+) | 150.1 | 1.62 | l‐Methionine | Increase lipid accumulation and reduces methylation (bovine) l |
(+) | 223.1 | 12.40 | Monobutyl phthalate | Impaired development to the blastocyst stage (mouse) h |
(+) | 126.0 | 0.71 | Taurine | Increased embryo viability (bovine) e ; increase development to blastocyst stage (rats) a |
Nakamura et al. (2016).
Gürke et al. (2016).
Nasr‐Esfahani and Johnson (1991).
Ain and Seshagiri (1997).
Ealy et al. (1992).
Yang, Greer, Van Vugt, and Reid (1995).
Miyazaki, Kuo, Dharmarajan, Atlas, and Wallach (1989).
Chu et al. (2013).
Kyvelidou et al. (2016).
Sutton‐McDowall, Feil, Robker, Thompson, and Dunning (2012).
González et al. (2012).
Acosta et al. (2016).